Relationship between the oxidative status and the tumor growth in transplanted triple-negative 4T1 breast tumor mice after oral administration of rhenium(I)-diselenoether-Reference-Cited by-同舟云学术

Relationship between the oxidative status and the tumor growth in transplanted triple-negative 4T1 breast tumor mice after oral administration of rhenium(I)-diselenoether

Published:2022-05 Issue: Volume:71 Page:126931
ISSN:0946-672X
Container-title:Journal of Trace Elements in Medicine and Biology
language:en
Short-container-title:Journal of Trace Elements in Medicine and Biology

Author:

Collery Philippe,Lagadec Patricia,Krossa Imène^ORCID,Cohen Charlotte,Antomarchi Julie,Varlet Didier^ORCID,Lucio Marianna,Guigonis Jean-Marie,Scimeca Jean-Claude^ORCID,Schmid-Antomarchi Heidy,Schmid-Alliana Annie

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Molecular Medicine,Biochemistry

Reference43 articles.

1. Design of rhenium compounds in targeted anticancer therapeutics;Collery;Curr. Pharm. Des.,2019

2. The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers;Collery;Invest. New Drugs,2019

3. A new model applied for evaluating a rhenium-diselenium drug: breast cancer cells stimulated by cytokines induced from polynuclear cells by LPS;Veena;Anticancer Res.,2020

4. Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer;Collery;Invest. New Drugs,2015

5. Dose effect of rhenium (I)-diselenoether as anticancer drug in resistant breast tumor-bearing mice after repeated administrations;Collery;Anticancer Res.,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo Model;Anticancer Research;2024-02-29

2. Remarkable Effects of a Rhenium(I)-diselenoether Drug on the Production of Cathepsins B and S by Macrophages and their Polarizations;Current Pharmaceutical Design;2023-08

3. Plasma Rhenium and Selenium Concentrations After Repeated Daily Oral Administration of Rhenium(I)-diselenoether in 4T1 Breast Tumor-bearing Mice;Anticancer Research;2023-02-28

4. Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects;European Journal of Medicinal Chemistry;2022-12

5. Leveraging the photophysical properties of rhenium(I) tricarbonyl complexes for biomedical applications;Biomedical Applications of Inorganic Photochemistry;2022